Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, attaching herewith Non-Applicability of Statement of deviation or variation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Ltd has informed BSE that it is not required to file a Statement of Deviation or Variation under SEBI's Listing Regulations. The company confirmed it has not raised any fresh funds through a public issue, rights issue, preferential issue, or qualified institutions placement. Since no such fundraising has taken place, the disclosure requirement does not apply. The communication was signed by Managing Director Jayendra Mehta on 11th November 2025.
This is a routine compliance filing with no material impact on shareholders. It simply confirms the company has not recently raised capital through specified routes, so there is no need to report any deviation in the use of issue proceeds.